Aveanna Healthcare Holdings (AVAH) Gains from Sales and Divestitures (2022 - 2024)
Historic Gains from Sales and Divestitures for Aveanna Healthcare Holdings (AVAH) over the last 3 years, with Q4 2024 value amounting to $688865.0.
- Aveanna Healthcare Holdings' Gains from Sales and Divestitures rose 12361.75% to $688865.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $688865.0, marking a year-over-year increase of 12361.75%. This contributed to the annual value of $688865.0 for FY2024, which is 12361.75% up from last year.
- Per Aveanna Healthcare Holdings' latest filing, its Gains from Sales and Divestitures stood at $688865.0 for Q4 2024, which was up 12361.75% from $308055.0 recorded in Q4 2023.
- In the past 5 years, Aveanna Healthcare Holdings' Gains from Sales and Divestitures ranged from a high of $688865.0 in Q4 2024 and a low of $308055.0 during Q4 2023
- Over the past 3 years, Aveanna Healthcare Holdings' median Gains from Sales and Divestitures value was $321053.0 (recorded in 2022), while the average stood at $439324.3.
- As far as peak fluctuations go, Aveanna Healthcare Holdings' Gains from Sales and Divestitures plummeted by 404.86% in 2023, and later surged by 12361.75% in 2024.
- Quarter analysis of 3 years shows Aveanna Healthcare Holdings' Gains from Sales and Divestitures stood at $321053.0 in 2022, then decreased by 4.05% to $308055.0 in 2023, then soared by 123.62% to $688865.0 in 2024.
- Its Gains from Sales and Divestitures stands at $688865.0 for Q4 2024, versus $308055.0 for Q4 2023 and $321053.0 for Q4 2022.